{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:25:12Z","timestamp":1790504712694,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T00:00:00Z","timestamp":1329696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T00:00:00Z","timestamp":1329696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,1,3]]},"DOI":"10.1038\/onc.2012.33","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T14:10:43Z","timestamp":1329747043000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Constitutive proteasomal degradation of TWIST-1 in epithelial\u2013ovarian cancer stem cells impacts differentiation and metastatic potential"],"prefix":"10.1038","volume":"32","author":[{"given":"G","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A B","family":"Alvero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Craveiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-H","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M K","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Chefetz-Menaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-A","family":"Silasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,20]]},"reference":[{"key":"BFonc201233_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00441-007-0510-7","volume":"331","author":"MR Alison","year":"2008","unstructured":"Alison MR, Murphy G, Leedham S . Stem cells and cancer: a deadly mix. Cell Tissue Res 2008; 331: 109\u2013124.","journal-title":"Cell Tissue Res"},{"key":"BFonc201233_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","volume":"291","author":"D Vergara","year":"2010","unstructured":"Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 2010; 291: 59\u201366.","journal-title":"Cancer Lett"},{"key":"BFonc201233_CR3","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/cncr.23044","volume":"110","author":"DK Espey","year":"2007","unstructured":"Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E et al. Annual report to the nation on the status of cancer, 1975\u20132004, featuring cancer in American Indians and Alaska Natives. Cancer 2007; 110: 2119\u20132152.","journal-title":"Cancer"},{"key":"BFonc201233_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"BFonc201233_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/sonc.2002.31589","volume":"29","author":"D Mutch","year":"2002","unstructured":"Mutch D . Surgical manegement of ovarian cancer. Semin Oncol 2002; 29: 3\u20138.","journal-title":"Semin Oncol"},{"issue":"Suppl 10","key":"BFonc201233_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1200\/JCO.2003.04.003","volume":"21","author":"SA Cannistra","year":"2003","unstructured":"Cannistra SA, Bast Jr RC, Berek JS, Bookman MA, Crum CP, DePriest PD et al. Progress in the management of gynecologic cancer: consensus summary statement. J Clin Oncol 2003; 21 (Suppl 10): 129\u2013132.","journal-title":"J Clin Oncol"},{"key":"BFonc201233_CR7","first-page":"99","volume":"107","author":"PE Schwartz","year":"2002","unstructured":"Schwartz PE . Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res 2002; 107: 99\u2013118.","journal-title":"Cancer Treat Res"},{"key":"BFonc201233_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Kaye SB . Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 2003; 3: 502\u2013516.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201233_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1056\/NEJMcp0901926","volume":"361","author":"DL Clarke-Pearson","year":"2009","unstructured":"Clarke-Pearson DL . Clinical practice. Screening for ovarian cancer. N Engl J Med 2009; 361: 170\u2013177.","journal-title":"N Engl J Med"},{"key":"BFonc201233_CR10","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","volume":"65","author":"D Fang","year":"2005","unstructured":"Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65: 9328\u20139337.","journal-title":"Cancer Res"},{"key":"BFonc201233_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/0090-8258(86)90136-8","volume":"23","author":"JT Chambers","year":"1986","unstructured":"Chambers JT, Schwartz PE . Treatment of persistent or recurrent ovarian carcinoma with sequential methotrexate and 5-fluorouracil. Gynecol Oncol 1986; 23: 346\u2013349.","journal-title":"Gynecol Oncol"},{"key":"BFonc201233_CR12","doi-asserted-by":"publisher","first-page":"23598","DOI":"10.1074\/jbc.M602191200","volume":"281","author":"M Yang","year":"2006","unstructured":"Yang M, Mailhot G, Birnbaum MJ, MacKay CA, Mason-Savas A, Odgren PR . Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis. J Biol Chem 2006; 281: 23598\u201323605.","journal-title":"J Biol Chem"},{"key":"BFonc201233_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1513\/pats.200711-166DR","volume":"5","author":"DC Radisky","year":"2008","unstructured":"Radisky DC, Przybylo JA . Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung. Proc Am Thorac Soc 2008; 5: 316\u2013322.","journal-title":"Proc Am Thorac Soc"},{"key":"BFonc201233_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP . Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131\u2013142.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc201233_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704\u2013715.","journal-title":"Cell"},{"key":"BFonc201233_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","volume":"15","author":"JP Thiery","year":"2003","unstructured":"Thiery JP . Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740\u2013746.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc201233_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1432-0436.2007.00210.x","volume":"75","author":"CL Chaffer","year":"2007","unstructured":"Chaffer CL, Dopheide B, Savagner P, Thompson EW, Williams ED . Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. Differentiation 2007; 75: 831\u2013842.","journal-title":"Differentiation"},{"key":"BFonc201233_CR18","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL et al. Cancer stem cells\u2014perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006; 66: 9339\u20139344.","journal-title":"Cancer Res"},{"key":"BFonc201233_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.stem.2008.05.007","volume":"2","author":"DC Radisky","year":"2008","unstructured":"Radisky DC, LaBarge MA . Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2008; 2: 511\u2013512.","journal-title":"Cell Stem Cell"},{"key":"BFonc201233_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10911-009-9110-3","volume":"14","author":"BG Hollier","year":"2009","unstructured":"Hollier BG, Evans K, Mani SA . The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia 2009; 14: 29\u201343.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BFonc201233_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/cc.8.1.7533","volume":"8","author":"AB Alvero","year":"2009","unstructured":"Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 2009; 8: 158\u2013166.","journal-title":"Cell Cycle"},{"key":"BFonc201233_CR22","doi-asserted-by":"publisher","first-page":"620523","DOI":"10.1155\/2011\/620523","volume":"2011","author":"KD Steffensen","year":"2011","unstructured":"Steffensen KD, Alvero AB, Yang Y, Waldstrom M, Hui P, Holmberg JC et al. Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J Oncol 2011; 2011: 620523.","journal-title":"J Oncol"},{"key":"BFonc201233_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/01913120903086072","volume":"33","author":"Q Gao","year":"2009","unstructured":"Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z . Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3. Ultrastruct Pathol (Res Supp, Non-US Gov\u2019t) 2009; 33: 175\u2013181.","journal-title":"Ultrastruct Pathol (Res Supp, Non-US Gov\u2019t)"},{"key":"BFonc201233_CR24","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","volume":"65","author":"SA Bapat","year":"2005","unstructured":"Bapat SA, Mali AM, Koppikar CB, Kurrey NK . Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005; 65: 3025\u20133029.","journal-title":"Cancer Res"},{"key":"BFonc201233_CR25","first-page":"5658","volume":"68","author":"L Moserle","year":"2008","unstructured":"Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S et al. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res (Res Supp, Non-US Gov\u2019t) 2008; 68: 5658\u20135668.","journal-title":"Cancer Res (Res Supp, Non-US Gov\u2019t)"},{"key":"BFonc201233_CR26","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA (Res Supp, N.I.H., Extramural Res Supp, Non-US Gov\u2019t) 2006; 103: 11154\u201311159.","journal-title":"Proc Natl Acad Sci USA (Res Supp, N.I.H., Extramural Res Supp, Non-US Gov\u2019t)"},{"key":"BFonc201233_CR27","first-page":"368","volume":"16","author":"MD Curley","year":"2011","unstructured":"Curley MD, Garrett LA, Schorge JO, Foster R, Rueda BR . Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer. Front Biosci (Res Supp, N.I.H., Extramural Res Supp, Non-US Gov\u2019t Review) 2011; 16: 368\u2013392.","journal-title":"Front Biosci (Res Supp, N.I.H., Extramural Res Supp, Non-US Gov\u2019t Review)"},{"key":"BFonc201233_CR28","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","volume":"27","author":"MD Curley","year":"2009","unstructured":"Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009; 27: 2875\u20132883.","journal-title":"Stem Cells"},{"key":"BFonc201233_CR29","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008; 68: 4311\u20134320.","journal-title":"Cancer Res"},{"key":"BFonc201233_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0897.2006.00441.x","volume":"57","author":"R Chen","year":"2007","unstructured":"Chen R, Alvero AB, Silasi DA, Mor G . Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol 2007; 57: 93\u2013107.","journal-title":"Am J Reprod Immunol"},{"key":"BFonc201233_CR31","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1038\/onc.2008.112","volume":"27","author":"R Chen","year":"2008","unstructured":"Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I et al. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008; 27: 4712\u20134723.","journal-title":"Oncogene"},{"key":"BFonc201233_CR32","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4161\/cbt.11.8.14967","volume":"11","author":"G Mor","year":"2011","unstructured":"Mor G, Yin G, Chefetz I, Yang Y, Alvero A . Ovarian cancer stem cells and inflammation. Cancer Biol Ther 2011; 11: 708\u2013713.","journal-title":"Cancer Biol Ther"},{"key":"BFonc201233_CR33","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/stem.191","volume":"27","author":"AB Alvero","year":"2009","unstructured":"Alvero AB, Fu HH, Holmberg J, Visintin I, Mor L, Marquina CC et al. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 2009; 27: 2405\u20132413.","journal-title":"Stem Cells"},{"key":"BFonc201233_CR34","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1371\/journal.pbio.0060316","volume":"6","author":"AB Sharabi","year":"2008","unstructured":"Sharabi AB, Aldrich M, Sosic D, Olson EN, Friedman AD, Lee SH et al. Twist-2 controls myeloid lineage development and function. PLoS Biol 2008; 6: e316.","journal-title":"PLoS Biol"},{"key":"BFonc201233_CR35","first-page":"3851","volume":"24","author":"O Watanabe","year":"2004","unstructured":"Watanabe O, Imamura H, Shimizu T, Kinoshita J, Okabe T, Hirano A et al. Expression of twist and wnt in human breast cancer. Anticancer Res 2004; 24: 3851\u20133856.","journal-title":"Anticancer Res"},{"key":"BFonc201233_CR36","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927\u2013939.","journal-title":"Cell"},{"key":"BFonc201233_CR37","doi-asserted-by":"publisher","first-page":"14665","DOI":"10.1074\/jbc.M707429200","volume":"283","author":"GZ Cheng","year":"2008","unstructured":"Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M et al. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem 2008; 283: 14665\u201314673.","journal-title":"J Biol Chem"},{"key":"BFonc201233_CR38","first-page":"1501","volume":"27","author":"EH Gort","year":"2008","unstructured":"Gort EH, van Haaften G, Verlaan I, Groot AJ, Plasterk RH, Shvarts A et al. The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene (Res Supp, Non-US Gov\u2019t) 2008; 27: 1501\u20131510.","journal-title":"Oncogene (Res Supp, Non-US Gov\u2019t)"},{"key":"BFonc201233_CR39","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1158\/1535-7163.MCT-11-0023","volume":"10","author":"AB Alvero","year":"2011","unstructured":"Alvero AB, Montagna MK, Holmberg JC, Craveiro V, Brown D, Mor G . Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther 2011; 10: 1385\u20131393.","journal-title":"Mol Cancer Ther"},{"key":"BFonc201233_CR40","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.4161\/cc.10.13.16348","volume":"10","author":"I Chefetz","year":"2011","unstructured":"Chefetz I, Holmberg JC, Alvero AB, Visintin I, Mor G . Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFkB pathway. Cell Cycle 2011; 10: 2206\u20132214.","journal-title":"Cell Cycle"},{"key":"BFonc201233_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4161\/cbt.11.8.14967","volume":"11","author":"G Mor","year":"2011","unstructured":"Mor G, Yin G, Chefetz I, Yang Y, Alvero A . Ovarian cancer stem cells and inflammation. Cancer Biol Ther 2011; 11: 708\u2013713.","journal-title":"Cancer Biol Ther"},{"key":"BFonc201233_CR42","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG . Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429\u20131437.","journal-title":"J Clin Invest"},{"key":"BFonc201233_CR43","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/bcr2326","volume":"11","author":"C Alix-Panabieres","year":"2009","unstructured":"Alix-Panabieres C, Vendrell JP, Slijper M, Pelle O, Barbotte E, Mercier G et al. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 2009; 11: R39.","journal-title":"Breast Cancer Res"},{"key":"BFonc201233_CR44","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1210\/endo.143.4.8726","volume":"143","author":"SF Carambula","year":"2002","unstructured":"Carambula SF, Matikainen T, Lynch MP, Flavell RA, Goncalves PB, Tilly JL et al. Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum. Endocrinology 2002; 143: 1495\u20131501.","journal-title":"Endocrinology"},{"key":"BFonc201233_CR45","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/onc.2009.397","volume":"29","author":"C Hader","year":"2010","unstructured":"Hader C, Marlier A, Cantley L . Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2. Oncogene 2010; 29: 1031\u20131040.","journal-title":"Oncogene"},{"key":"BFonc201233_CR46","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ki.2009.102","volume":"75","author":"W Bechtel","year":"2009","unstructured":"Bechtel W, Zeisberg M . Twist: a new link from hypoxia to fibrosis. Kidney Int 2009; 75: 1255\u20131256.","journal-title":"Kidney Int"},{"key":"BFonc201233_CR47","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2353\/ajpath.2010.091270","volume":"177","author":"C Horbinski","year":"2010","unstructured":"Horbinski C, Mojesky C, Kyprianou N . Live free or die: tales of homeless (cells) in cancer. Am J Pathol 2010; 177: 1044\u20131052.","journal-title":"Am J Pathol"},{"key":"BFonc201233_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/nar\/gkn920","volume":"37","author":"YB Lee","year":"2009","unstructured":"Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB . Twist-1 regulates the miR-199a\/214 cluster during development. Nucleic Acids Res 2009; 37: 123\u2013128.","journal-title":"Nucleic Acids Res"},{"key":"BFonc201233_CR49","doi-asserted-by":"publisher","first-page":"34623","DOI":"10.1074\/jbc.M707085200","volume":"282","author":"KB Laursen","year":"2007","unstructured":"Laursen KB, Mielke E, Iannaccone P, Fuchtbauer EM . Mechanism of transcriptional activation by the proto-oncogene Twist1. J Biol Chem 2007; 282: 34623\u201334633.","journal-title":"J Biol Chem"},{"key":"BFonc201233_CR50","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","volume":"7","author":"J Comijn","year":"2001","unstructured":"Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267\u20131278.","journal-title":"Mol Cell"},{"key":"BFonc201233_CR51","doi-asserted-by":"publisher","first-page":"18969","DOI":"10.1073\/pnas.0608636103","volume":"103","author":"KA Hartwell","year":"2006","unstructured":"Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, Weinberg RA . The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA 2006; 103: 18969\u201318974.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201233_CR52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/dvdy.20345","volume":"233","author":"ED Hay","year":"2005","unstructured":"Hay ED . The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005; 233: 706\u2013720.","journal-title":"Dev Dyn"},{"key":"BFonc201233_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ccr.2004.09.033","volume":"6","author":"S Valsesia-Wittmann","year":"2004","unstructured":"Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V et al. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 2004; 6: 625\u2013630.","journal-title":"Cancer Cell"},{"key":"BFonc201233_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ijc.21068","volume":"117","author":"N Entz-Werle","year":"2005","unstructured":"Entz-Werle N, Stoetzel C, Berard-Marec P, Kalifa C, Brugiere L, Pacquement H et al. Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer 2005; 117: 349\u2013355.","journal-title":"Int J Cancer"},{"key":"BFonc201233_CR55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/hmg\/9.5.813","volume":"9","author":"V El Ghouzzi","year":"2000","unstructured":"El Ghouzzi V, Legeai-Mallet L, Aresta S, Benoist C, Munnich A, de Gunzburg J et al. Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. Hum Mol Genet 2000; 9: 813\u2013819.","journal-title":"Hum Mol Genet"},{"key":"BFonc201233_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1165\/rcmb.2007-0071OC","volume":"38","author":"Y Shintani","year":"2008","unstructured":"Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ . Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. Am J Respir Cell Mol Biol 2008; 38: 95\u2013104.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFonc201233_CR57","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cell.2007.01.014","volume":"128","author":"C Blanpain","year":"2007","unstructured":"Blanpain C, Horsley V, Fuchs E . Epithelial stem cells: turning over new leaves. Cell 2007; 128: 445\u2013458.","journal-title":"Cell"},{"key":"BFonc201233_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih Ie M . The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010; 34: 433\u2013443.","journal-title":"Am J Surg Pathol"},{"key":"BFonc201233_CR59","first-page":"584","volume":"203","author":"M Shih Ie","year":"2010","unstructured":"Shih Ie M, Chen L, Wang CC, Gu J, Davidson B, Cope L et al. Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis. Am J Obstet Gynecol 2010; 203: 584, e1\u201322.","journal-title":"Am J Obstet Gynecol"},{"key":"BFonc201233_CR60","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1038\/sj.onc.1206422","volume":"22","author":"M Kamsteeg","year":"2003","unstructured":"Kamsteeg M, Rutherford T, Sapi E, Hanczaruk B, Shahabi S, Flick M et al. Phenoxodiol\u2014an isoflavone analog\u2014induces apoptosis in chemoresistant ovarian cancer cells. Oncogene 2003; 22: 2611\u20132620.","journal-title":"Oncogene"},{"key":"BFonc201233_CR61","first-page":"5573","volume":"63","author":"V Abrahams","year":"2003","unstructured":"Abrahams V, Straszewski S, Kamsteeg M, Hanczaruk B, Schwartz P, Rutherford T et al. Epithelial ovarian cancer secrete funcitonal Fas ligand. Cancer Res 2003; 63: 5573\u20135581.","journal-title":"Cancer Res"},{"key":"BFonc201233_CR62","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.4161\/cbt.8.18.9285","volume":"8","author":"JM Green","year":"2009","unstructured":"Green JM, Alvero AB, Kohen F, Mor G . 7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: a novel compound capable of inducing cell death in epithelial ovarian cancer stem cells. Cancer Biol Ther 2009; 8: 1747\u20131753.","journal-title":"Cancer Biol Ther"},{"key":"BFonc201233_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1600-0897.2008.00682.x","volume":"61","author":"K Koga","year":"2009","unstructured":"Koga K, Cardenas I, Aldo P, Abrahams VM, Peng B, Fill S et al. Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol 2009; 61: 196\u2013212.","journal-title":"Am J Reprod Immunol"},{"key":"BFonc201233_CR64","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-07-1569","volume":"14","author":"I Visintin","year":"2008","unstructured":"Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y et al. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res 2008; 14: 1065\u20131072.","journal-title":"Clin Cancer Res"},{"key":"BFonc201233_CR65","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101\u20131108.","journal-title":"Nat Protoc"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201233","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:20:06Z","timestamp":1647886806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,20]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1,3]]}},"alternative-id":["BFonc201233"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.33","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,20]]},"assertion":[{"value":"3 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}